about
Cancer stem cells: the lessons from pre-cancerous stem cellsSerum amyloid A: an acute-phase protein involved in tumour pathogenesisTRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroidsIgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver diseaseCD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells.Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responsesBridging innate and adaptive antitumor immunity targeting glycans.Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrencesGene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-α and dendritic cell vaccine.Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.Modulation of the antitumor immune response by complement.Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer modelsA subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1.ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy.Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study.Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.Tumor stress, cell death and the ensuing immune response.IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.T-cell activation is enhanced by targeting IL-10 cytokine production in toll-like receptor-stimulated macrophages.In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cells.Is complement good or bad for cancer patients? A new perspective on an old dilemma.Real-world impact of education: treating patients with ipilimumab in a community practice settingOvarian tumor-induced T cell suppression is alleviated by vascular leukocyte depletion.Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.The Roles of Radiotherapy and Immunotherapy for the Treatment of LymphomaPolymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors.Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.The response of human dendritic cells to co-ligation of pattern-recognition receptors.Mechanisms of action of tasquinimod on the tumour microenvironment.Sarcoma immunotherapy: past approaches and future directions.Adoptive immunotherapy against sarcomas.Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy.Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer.Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model.CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).NKT Cell Responses to B Cell Lymphoma.Preparation of tumor antigen-loaded mature dendritic cells for immunotherapy.Impacts of K562 cells towards activities of Toll-like receptor pathway of human mesenchymal stem cell-bone marrow.TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.
P2860
Q28259527-9F45388F-C81B-4968-A644-17ECD095B08AQ28291806-53D65317-3103-46C7-A2A6-523B08607CD7Q28544399-4CB15EF0-7BD7-4502-86C9-0AA94FB7E769Q28727095-362EAB27-E34E-4D8B-8694-15B5B49B5C7CQ33618936-8A56EA65-E181-489E-8642-92028B3A5C46Q33620107-0C10E65E-0180-48D6-ADC4-389F929977B6Q33960021-C26EA444-B294-4895-852C-ACFB84540819Q34354547-4CB0AA57-6C47-4DAF-A364-F68107E812D8Q34506479-205BA8F2-3C14-47A7-AF5E-AD1A798D369EQ34775944-9A1ED2B3-A41F-432F-BEB3-93A849E685C8Q34838919-3D4AC5BB-BCC7-4A4F-AB6B-4CAD03BA8D79Q34904172-09B210E8-6C66-40B9-95D4-E7A71159B65FQ35640574-52E36859-27FE-4919-A56F-D45CEE4F7B33Q35695370-8FF3A9FB-B9BD-46B9-B271-19AECC128BBEQ36490577-C434194A-4EB7-485D-8E92-28944608D3EBQ36712736-5188D007-C156-48A5-9814-F3FC457457F3Q36997144-BBE70F83-B418-4F32-95E1-5EA900447CDDQ37052943-546A665B-A5F3-4A86-AC91-A11D43C234B5Q37068321-79B4921D-41BD-447E-886F-32ACDF3B68A5Q37220754-D5685A74-2D07-45BD-9095-E3D5DFECE346Q37247425-5114F6EA-B77D-4B55-9166-3A8B3201A777Q37414993-ABDDD912-EB98-4281-87F2-F491DCA3BEF8Q37429892-F4DBB066-6039-4CDC-8E33-0763612E8F35Q37507341-303AF67F-F74C-42B2-B706-4B548CD31779Q37640319-47FD71C7-F4E2-4F4C-8942-201118CB08E3Q37646545-EF23D315-BA56-45FC-A0D6-AEB00D0D9D03Q37705029-DC1D1C76-EFCD-43F3-BB3E-1E58EE7EE128Q37990783-55F64C80-0965-42E1-80EC-AFCF0CF3CDC0Q38155757-CBD5A575-4F5C-4AB4-83D6-AEFE947D2821Q38207986-441BC057-13DB-4173-A650-A9723E19D3D0Q38291193-08712D0F-D2E6-4D46-A34A-45DE3BB8524EQ38293525-7E8D472B-6218-4D5A-B93D-AAF0012EDC4BQ38390089-6D9F3EC4-1A2A-4A9D-8B01-8D6A7267866BQ38627218-90A2EF28-EFF5-4F01-9BDA-D2F0F35B1159Q38975033-63DF0094-C3A0-4BA7-985D-F48B2FC61759Q40732246-8A1B3842-EB6D-441E-9A70-0FB31E2D071EQ40894586-3F2B6F55-5313-41F8-A66F-9B59510D96FDQ41855097-7DAF85ED-99C0-4732-BBA9-CCCAE5257DD9Q41887599-8AD5885B-E020-4750-92B0-B90039A8D658Q41994790-7002AD69-A896-4F31-B368-E77F17303E5A
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Harnessing the immune system to treat cancer.
@ast
Harnessing the immune system to treat cancer.
@en
type
label
Harnessing the immune system to treat cancer.
@ast
Harnessing the immune system to treat cancer.
@en
prefLabel
Harnessing the immune system to treat cancer.
@ast
Harnessing the immune system to treat cancer.
@en
P2860
P356
P1476
Harnessing the immune system to treat cancer.
@en
P2093
Nina Bhardwaj
P2860
P304
P356
10.1172/JCI32136
P407
P577
2007-05-01T00:00:00Z